Both are legitimate peptide + TRT clinics with overlapping formularies. Defy Medical wins on peptide breadth and established reputation (founded 2016). Limitless Alt Med wins on price transparency, free consultations, oral testosterone option, and the fact that 95% of their treatments ship without requiring bloodwork upfront.
| Defy Medical | Limitless Alt Med | |
|---|---|---|
| Monthly Cost | ~$200/mo+ (not published) | TRT $115–$170/mo (published) |
| Consultation Fee | Not included (separate) | Free |
| Labs Required? | Yes — required upfront | No (95% ship without labs) |
| Est. Lab Cost | $100–$300/yr | $150/yr (TRT monitoring, 4x/yr) |
| Oral Testosterone | No (injectable only) | Yes — both oral + injectable |
| BPC-157 | Yes | $325/injectable |
| PT-141 | Limited | $184 |
| Sermorelin | Yes (full protocol) | $194 |
| NAD+ | Yes | $180/vial |
| Tesamorelin / Epithalon | Yes | Not confirmed |
| IGF-1 LR3 / Kisspeptin | Yes (niche peptides) | Not confirmed |
| GLP-1 | Limited | Sema sublingual $200, Tirze $275–$400 |
| Founded | 2016 — Dr. Justin Saya | Telehealth platform |
| Trustpilot | 4.2/5 (3,700+) | Growing |
| Full Review | Read Review → | Read Review → |
Limitless Alternative Medicine publishes a catalog of protocol pricing: TRT medication $115–$170/month, BPC-157 injectable $325, PT-141 $184, Sermorelin $194, NAD+ $180/vial, Semaglutide sublingual $200. Consultations are free. This level of transparency makes it easy to evaluate costs before committing.
Defy Medical requires direct contact for any pricing. Consultations are billed separately (estimated $500–$600+ for initial visit with labs), and medication costs are not published. For users who want to compare line-by-line before enrolling, Limitless Alt Med has a structural advantage.
Not published. Consult fee not included. Labs required: $100–$300/yr. Per-service billing throughout.
Published catalog pricing. Free consultations. TRT $115–$170/mo. 95% of treatments ship without prior bloodwork.
Both clinics carry core peptides including BPC-157, Sermorelin, NAD+, and GHK-Cu blends. Limitless Alt Med also offers PT-141 at a published price ($184), which Defy Medical has limited availability of.
Where Defy Medical differentiates is in niche peptides: Tesamorelin, IGF-1 LR3, Kisspeptin, MOTS-C, Epithalon, and AOD-9604. If your protocol requires any of these, Defy Medical is the better clinic. For core peptide access at transparent pricing, Limitless Alt Med is competitive.
For users who need niche peptides (Tesamorelin, IGF-1 LR3, MOTS-C, Kisspeptin), Defy Medical remains the better clinic — the wider formulary and decade-long track record carry real weight.
For users who want transparent pricing, free consultations, oral TRT options, and the ability to start without upfront bloodwork, Limitless Alt Med is a compelling alternative. Their PT-141 at $184 and BPC-157 at $325 with published pricing remove the guesswork that Defy Medical requires.
Yes. Limitless Alt Med publishes injectable BPC-157 at $325. Defy Medical also carries BPC-157 but does not publish pricing — you'll need to contact them directly for current costs.
Limitless Alt Med is more transparent: TRT $115–$170/mo, free consultations, and most treatments ship without labs. Defy Medical's total costs are higher, with labs adding $100–$300/yr on top of unpublished protocol costs.
Yes — oral and injectable TRT are both available, which is a meaningful differentiator. Many telehealth TRT clinics only offer injections.